Docosatetraenoyl Ethanolamide – 25 mg

Brand:
Cayman
CAS:
150314-35-5
Storage:
-20
UN-No:
De Minimis - 1170 / 3

Docosatetraenoyl ethanolamide (DEA) is an endocannabinoid containing docosatetraenoic acid in place of the arachidonate moiety of AEA. DEA acts on CB1 receptors with potency and efficacy similar to that of AEA.{2713} However, its specific role and relative importance as a cannabinergic neurotransmitter have not been elucidated.{1172}  

 

Available on backorder

SKU: 90385 - 25 mg Category:

Description

An endocannabinoid containing docosatetraenoic acid in place of the arachidonate moiety of AEA; acts on CB1 receptors with a potency and efficacy similar to that of AEA but its specific role and relative importance as a cannabinergic neurotransmitter have not been elucidated


Formal name: N-(2-hydroxyethyl)-7Z,10Z,13Z,16Z-docosatetraenamide

Synonyms:  DEA

Molecular weight: 375.6

CAS: 150314-35-5

Purity: ≥98%

Formulation: A solution in ethanol